Integrating Comprehensive Cardiovascular Care into Patient-Centered Diabetes Treatment

Integrating Comprehensive Cardiovascular Care into Patient-Centered Diabetes Treatment

On-Demand Webcast

Richard E. Pratley, MD
Samuel Crockett Chair in Diabetes Research
Medical Director, AdventHealth Diabetes Institute
Senior Scientist and Diabetes Program Head,
AdventHealth Translational Research Institute for Metabolism and Diabetes
Orlando, Florida


Provided by North American Center for Continuing Medical Education, LLC, an HMP Company and the National Committee for Quality Assurance.

For questions regarding this educational activity, please call 609-371-1137 or email

Intended Learners

This activity is intended for professionals devoted to transforming care through the medical home model of care, including physicians, allied health professionals, practice administrators, quality managers, and consultants.


After completing this activity, participants should be able to:

  • Integrate the latest cardiovascular trial outcomes and updated cardiovascular indications for antidiabetic agents into treatment plans.
  • Describe recent guideline updates for diabetes and cardiovascular disease treatment.
  • Apply components of successful collaborative, patient-centered models to individual healthcare systems and practices.

To be eligible for credit, participants must complete the online activity, a post-test assessment, and the evaluation. Upon completing the activity, there will be instructions on how to print a certificate or other documentation of credit.

Release Date: October 25, 2019
Expiration Date: October 25, 2020
Estimated Time to Complete: 0.75 hours

Commercial Support

Supported by an educational grant from Novo Nordisk, Inc.


In support of improving patient care, the National Committee for Quality Assurance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), the American Academy of Physician Assistants (AAPA), the American Psychological Association (APA), and the Association of Social Work Boards (ASWB) to provide Interprofessional Continuing Education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.

This educational activity is approved for 0.75 AMA PRA Category 1 CreditsTM, ANA CNE, APA, ACPE and ASWB ACE.

The assigned universal program number(s):­­­­­­­­­­­­­­­­­­­­­ JA0004597-0000-19-016-H04-P. Upon successful completion of this program (attending the full session and completing a program evaluation), participants will access CPE Monitor on the ACPE website to locate and track their CPE statement of credit.


The evaluation is accessible after the activity via a PC (Windows 7 or newer) or Mac (Mac OS 10.6 or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to


This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.


This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of NACCME.


The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

Neither NACCME nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.

The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.


NACCME, LLC is an independent provider(s) of continuing medical education. NACCME, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

NACCME, LLC assures that all educational materials are reviewed to ensure for the absence of commercial bias, fair balance, scientific objectivity, and levels of evidence. The educational activity will not be influenced by commercial organizations and will not conflict with any other scheduled educational activities.

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

Clinical Reviewers

Lorena Alarcon-Casas Wright, MD, FACE, University of Washington School of Medicine, Division of Metabolism, Endocrinology and Nutrition, UW Medicine Diabetes Institute, UW Endocrinology Care Center/Roosevelt, Harborview Medical Center, Seattle, Washington

Nurse Planner: Johann Chanin, Senior Consultant, Steadman Group, Denver, Colorado

Planning Committee

In addition to the staff listed below, planners and staff include: Jennifer D'Alessandro; Bart Ecker, NCQA; Kristin Ciszeski; Mary Johnson; Amanda Steinmayr; Tiffany Thomas; and Randy Robbin, CHCP, NACCME. 

The faculty has reported the following:

Dr. Pratley: Advisory Board/Consultant—AstraZeneca, GlaxoSmithKline, Glytec LLC, Janssen, Ligand, Lilly, Merck, Mundipharma, Novo Nordisk, Sanofi; Speaker—AstraZeneca, Novo Nordisk; Research Support—Lexicon, Ligand, Lilly, Merck, Novo Nordisk, Sanofi.

Dr. Wright disclosed no relevant financial relationships with any commercial interests.

The following drugs and/or medical devices are being discussed for an off-label use: Liraglutide—Recent data on the effects of liraglutide in patients with T2D in the LEADER study; Exenatide—Recent data on the effects of exenatide in patients with T2D in the Exscel study; Semaglutide—Recent data on the effects of semaglutide in patients with T2D in the SUSTAIN-6 study; Lixisenatide—Recent data on the effects of Lixisenatide in patients with T2D in the ELIXA study; Dapagliflozin—Recent data on the effects of dapagliflozin in patients with T2D in the DECLARE TIMI-58 study; Albiglutide—Recent data on the effects of Albiglutide in patients with T2D.


North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2019 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Jointly provided by North American Center for Continuing Medical Education, LLC, an HMP Company, and the National Committee for Quality Assurance.